CLDX

CELLDEX THERAPEUTICS INC NEW

CLDX·15117B202·US·Common Stock·Healthcare - Biotechnology-13D/G

CLDX (CELLDEX THERAPEUTICS INC NEW) is held by 115 institutional investors as of Q1 2026. Largest holders: WELLINGTON MANAGEMENT GROUP LLP ($271.5M), BlackRock, Inc. ($170.3M), FMR LLC ($118.9M). Net institutional sentiment: Mixed.

115
Holders
Avg rating(24 Elite)
$1.4B
Total Value
61% (119)
Fund Consensus
65 buying - 41 selling
CLDXSmart Money Verdict
View all
Held by 115 funds
24 elite
Who's Trading
ActivistKYKynam Capital Management, LP8.8%May 15, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION4.2%May 12, 2026
ActivistFMR LLCFMR LLC5.6%May 6, 2026
ActivistVAVanguard Capital Management5.2%Apr 29, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.2.6%Mar 10, 2026
InsiderJAJimenez Freddy A.Sell $121KDec 4, 2025
InsiderWMWright Richard M.Sell $1.2MNov 13, 2025
InsiderJAJimenez Freddy A.Sell $8KAug 13, 2025
InsiderJAJimenez Freddy A.Sell $11KAug 13, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
8.6M(+6.0%)$271.5M0.1%+11.60%
33
Decreased
5.4M(-1.5%)$170.3M0.0%+56.09%
0
Decreased
3.7M(-23.6%)$118.9M0.0%+59.18%
0
Increased
3.2M(+83.7%)$102.5M0.1%+32.72%
55
New
3M$93.9M0.0%+35.14%
41
Decreased
2.8M(-17.5%)$88.9M0.0%+16.28%
0
Increased
2.1M(+2.3%)$66.2M0.0%+6.37%
30
Increased
1.7M(+3.7%)$53.6M0.0%+22.40%
30
Increased
1.3M(+3.4%)$39.8M0.0%+55.21%
30
Increased
1.1M(+62.6%)$33.6M0.0%+47.38%
42
Increased
1M(+8.2%)$32.2M0.0%+44.58%
31
Decreased
988,416(-7.5%)$31.4M0.0%+54.42%
0
Decreased
923,696(-4.6%)$29.3M0.0%+44.21%
0
Increased
856,310(+0.1%)$27.2M0.0%+28.76%
29
Increased
708,647(+70.8%)$22.5M0.0%+54.92%
42
Unchanged
665,370$21.1M0.1%+42.22%
0
New
629,252$20M0.0%+35.14%
39
Increased
577,267(+5.0%)$18.3M0.0%+17.61%
30
Decreased
545,486(-0.9%)$17.3M0.0%-7.31%
0
Unchanged
500,127$15.9M0.1%+36.22%
0

Showing 1-20 of 119

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used